LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 76.75 | 770.25 | 2908 | 11262 | 0.2582 | 0.4096 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 76.75 | 770.25 | 5853 | 11262 | 0.5197 | 0.6888 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 78.98 | 770.25 | 3023 | 11518 | 0.2625 | 0.4196 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 78.98 | 770.25 | 6254 | 11518 | 0.5430 | 0.7103 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 81.20 | 770.25 | 3094 | 11766 | 0.2630 | 0.4241 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 81.20 | 770.25 | 6346 | 11766 | 0.5393 | 0.7095 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 83.42 | 770.25 | 3355 | 12031 | 0.2788 | 0.4493 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 83.42 | 770.25 | 6643 | 12031 | 0.5521 | 0.7218 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 85.64 | 770.25 | 3541 | 12287 | 0.2882 | 0.4649 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 85.64 | 770.25 | 7016 | 12287 | 0.5710 | 0.7383 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 87.86 | 770.25 | 3752 | 12543 | 0.2991 | 0.4819 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 87.86 | 770.25 | 7320 | 12543 | 0.5836 | 0.7495 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 3.21 | 770.25 | 934 | 904 | 1.0325 | 1.2954 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 3.21 | 770.25 | 793 | 904 | 0.8766 | 0.1337 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 5.44 | 770.25 | 1004 | 1012 | 0.9914 | 0.9565 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 5.44 | 770.25 | 839 | 1012 | 0.8284 | 0.2417 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 7.66 | 770.25 | 1084 | 1090 | 0.9945 | 0.9781 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 7.66 | 770.25 | 873 | 1090 | 0.8009 | 0.2840 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 10.06 | 770.25 | 1172 | 1218 | 0.9618 | 0.8858 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 10.06 | 770.25 | 938 | 1218 | 0.7698 | 0.3469 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 12.28 | 770.25 | 1209 | 1358 | 0.8902 | 0.7350 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 12.28 | 770.25 | 991 | 1358 | 0.7297 | 0.3607 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 14.50 | 770.25 | 1260 | 1497 | 0.8415 | 0.6707 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 14.50 | 770.25 | 1028 | 1497 | 0.6866 | 0.3512 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 16.73 | 770.25 | 1293 | 1664 | 0.7768 | 0.5936 | MN20160304_L02 | E08 |